Outcome of patients receiving thrombolytic therapy while on Rivaroxaban for nonvalvular atrial fibrillation (from Rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation) - Chen, Sean T.; Hacke, Werner (The American journal of cardiology, 2017)
Gesehen am: 23.10.2017